뉴스벤징가
Bristol-Myers Boosts 2026 Guidance on Portfolio Strength
· 발표
기사 요약
Bristol-Myers beats Q2 earnings and revenue estimates, driven by growth drugs, while raising its full-year 2026 sales and profit outlook.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Bristol-Myers beats Q2 earnings and revenue estimates, driven by growth drugs, while raising its full-year 2026 sales and profit outlook.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…